[VYNE] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
17-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- 45.64%
YoY- 50.09%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 167 126 178 2,292 4,086 4,258 4,119 -88.17%
PBT -9,255 -8,235 -8,694 -12,018 -21,285 -19,924 -20,550 -41.21%
Tax 204 241 -13,364 -448 3,439 1,005 1,005 -65.42%
NP -9,459 -8,476 4,670 -11,570 -21,285 -19,924 -20,550 -40.35%
Tax Rate - - - - - - - -
Total Cost 9,626 8,602 -4,492 13,862 25,371 24,182 24,669 -46.57%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -5,664.07 -6,726.98 2,623.60 -504.80 -520.93 -467.92 -498.91 404.38%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -2.94 -2.63 1.52 -3.89 -7.36 -6.98 -7.57 -46.73%
EPS Diluted -2.94 -2.63 1.52 -3.89 -7.36 -6.98 -7.57 -46.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.